Onihomikoze Kod Pacijenata Obolelih Od Hronične Venske Insuficijencije

1 Bajuk V, Leskovec NK, Ručigaj TP, Suhodolčan AB, Dolenc-Voljč M. Toenail alterations in chronic venous disease patients are not always of mycotic origin. Phlebology. 2019;34(6):421-6. Search in Google Scholar

2 Shemer A, Nathanson H, Kaplan B, Trau H. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat? J Eur Acad Dermatol Venereol. 2008;22(3):279-82. Search in Google Scholar

3 Sáez de Ocariz MM, Arenas R, Ranero-Juárez GA, Farrera-Esponda F, Monroy-Ramos E. Frequency of toenail onychomycosis in patients with cutaneous manifestations of chronic venous insufficiency. Int J Dermatol. 2001;40(1):18-25. Search in Google Scholar

4 Cañete-Gibas C, Wiederhold NP. Mycology of onychomycosis. Clin Microbiol Newsl. 2023;45(2):11-7. Search in Google Scholar

5 Piraccini BM, Starace M, Rubin AI, Di Chiacchio NG, Iorizzo M, Rigopoulos D. Onychomycosis: recommendations for diagnosis, assessment of treatment efficacy, and specialist referral. The CONSONANCE consensus project. Dermatol Ther (Heidelb). 2022; 12 (4):885-98. Search in Google Scholar

6 Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019; 80-(4):835-51. Search in Google Scholar

7 Falotico JM, Lipner SR. Updated perspectives on the diagnosis and management of onychomycosis. Clin Cosmet Investig Dermatol. 2022;15:1933-57. Search in Google Scholar

8 Leung AKC, Lam JM, Leong KF, Hon KL, Barankin B, Leung AAM, et al. Onychomycosis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45. Search in Google Scholar

9 Gupta A, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, et al. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972-90. Search in Google Scholar

10 Gupta AK, Wang T, Polla Ravi S, Mann A, Bamimore MA. Global prevalence of onychomycosis in general and special populations: an updated perspective. Mycoses. 2024;67(4):e13725. Search in Google Scholar

11 Gupta AK, Elewski B, Joseph WS, Lipner SR, Daniel CR, Tosti A, et al. Treatment of onychomycosis in an era of antifungal resistance: role for antifungal stew-ardship and topical antifungal agents. Mycoses. 2024;67(1):e13683. Search in Google Scholar

12 Van der Weerden NL, Parisi K, McKenna JA, Hayes BM, Harvey PJ, Quimbar P, et al. The plant defensin Ppdef1 is a novel topical treatment for onychomycosis. J Fungi (Basel). 2023;9(11):1111. Search in Google Scholar

13 Kulac M, Acar M, Karaca S, Cetinkaya Z, Albayrak R, Haktanir A, et al. Venous insufficiency in patients with toenail onychomycosis. J Ultrasound Med. 2005;24(8):1085-9. Search in Google Scholar

14 Cabete J, Galhardas C, Apetato M, Lestre S. Onychomycosis in patients with chronic leg ulcer and toenail abnormalities. An Bras Dermatol. 2015;90 (1):136-9. Search in Google Scholar

15 Albucker SJ, Falotico JM, Choo ZN, Matushansky JT, Lipner SR. Risk factors and treatment trends for onychomycosis: a case–control study of onychomycosis patients in the All of Us Research Program. J Fungi (Basel). 2023;9(7):712. Search in Google Scholar

16 Yousefian F, Smythe C, Han H, Elewski BE, Nestor M. Treatment options for onychomycosis: Eefficacy, side effects, adherence, financial considerations, and ethics. J Clin Aesthet Dermatol. 2024;17(3):24-33. Search in Google Scholar

17 Gregoriou S, Kyriazopoulou M, Tsiogka A, Rigopoulos D. Novel and investigational treatments for onychomycosis. J Fungi (Basel). 2022;8(10):1079. Search in Google Scholar

18 Moreno-Coutiño G, Sandoval-Navarro K, Lozano-Platonoff A, Toussaint-Caire S, Vega-Sánchez D. Chronic venous insufficiency associated to sub-clinical onychomycosis. International Journal of Dermatology Research. 2023;5(1):17-20. Search in Google Scholar

19 Lipner SR, Scher RK. Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853-67. Search in Google Scholar

20 Bang CH, Yoon JW, Lee HJ, Lee JY, Park YM, Lee SJ, et al. Evaluation of relationships between onychomycosis and vascular diseases using sequential pattern mining. Sci Rep. 2018;8(1):17840. Search in Google Scholar

21 Watjer RM, Heckmans KM, Eekhof JA, Gummi L, Quint KD, Numans ME, et al. Association between onychomycosis and ulcerative complications in patients with diabetes: a longitudinal cohort study in Dutch general practice. BMJ Open. 2024;14(4):e076441. Search in Google Scholar

22 Rossboth S, Rossboth B, Schoenherr H, Lechleitner M, Oberaigner W. Risk factors for diabetic foot complications among patients with type 2 diabetes in Austria-a registry-based retrospective cohort study. Endocrinol Diabetes Metab. 2021;4(4):e00286. Search in Google Scholar

23 Haneke E. Onychomycosis in foot and toe malformations. J Fungi (Basel). 2024;10(6):399. Search in Google Scholar

24 Papini M, Cicoletti M, Fabrizi V, Landucci P. Skin and nail mycoses in patients with diabetic foot. G Ital Dermatol Venereol. 2013;148(6):603-8. Search in Google Scholar

25 Shah KV, Desai AD, Lipner SR. Retrospective analysis of onychomycosis risk factors using the 2003-2014 National Inpatient Sample. Dermatol Pract Concept. 2024;14(2):e2024074. Search in Google Scholar

26 Buttars B, Scott SG, Glinka D, Daniel CR, Brodell RT, Braswell MA. Congenital malalignment of the great toenail, the disappearing nail bed, and distal phalanx deviation: a review. Skin Appendage Disord. 2022;8(1):8-12. Search in Google Scholar

27 Kılınç F, Akbaş A, Şener S, Hayran Y, Aktaş A. Cutaneous findings in patients with chronic venous insufficiency. J Cosmet Dermatol. 2022;21(5):2106-12. Search in Google Scholar

28 Lipner SR, Scher RK. Evaluation of nail lines: color and shape hold clues. Cleve Clin J Med. 2016;83 (5): 385-91. Search in Google Scholar

29 Falotico JM, Lapides R, Lipner SR. Combination therapy should be reserved as second-line treatment of onychomycosis: a systematic review of onychomycosis clinical trials. J Fungi (Basel). 2022; 8 (3) :279. Search in Google Scholar

30 Stalević M, Ignjatović A, Randjelović M, Otašević S. Risk factors and cluster analysis of onychomycosis. Acta Medica Medianae. 2023;62(4):29-36. Search in Google Scholar

31 Gupta AK, Mays RR, Versteeg SG, Shear NH, Piguet V. Update on current approaches to diagnosis and treatment of onychomycosis. Expert Rev Anti Infect Ther. 2018;16(12):929-38. Search in Google Scholar

32 Lim SS, Ohn J, Mun JH. Diagnosis of onychomycosis: from conventional techniques and dermoscopy to artificial intelligence. Front Med (Lausanne). 2021; 8:637216. Search in Google Scholar

33 Yorulmaz A, Yalcin B. Dermoscopy as a first step in the diagnosis of onychomycosis. Postepy Dermatol Alergol. 2018;35(3):251-8. Search in Google Scholar

34 Mahajan K, Grover C, Relhan V, Tahiliani S, Singal A, Shenoy MM, et al. Nail Society of India recommendations for treatment of onychomycosis in special population groups. Indian Dermatol Online J. 2024;15(2):196-204. Search in Google Scholar

35 Kim JK, Chung HC, Chun EJ, Kim S, Kim CW. Correlation between nail thickness and onychomycosis: Misuse of antifungal agents in patients with thick nails. Ann. Dermatol. 2024;36(2):123-4. Search in Google Scholar

36 Haneke E. Differential diagnosis of nail psoriasis and onychomycoses: a report based on 40 years of specialised nail consultations. EMJ Dermatol. 2020:00008. httsp://doi.org/10.33590/emj der ma tol /20-00008 Search in Google Scholar

37 Aldana-Caballero A, Mayordomo R, Marcos-Tejedor F. Assessment of visual diagnosis by podiatrists for HPV and onychomycosis: the need for complementary tests. J Fungi (Basel). 2022;8(2):135. Search in Google Scholar

38 Hay RJ. The spread of resistant tinea and the ingredients of a perfect storm. Dermatology. 2022; 238-(1):80-1. Search in Google Scholar

39 Dhamoon RK, Popli H, Gupta M. Novel drug delivery strategies for the treatment of onychomycosis. Pharm Nanotechnol. 2019;7(1):24-38. Search in Google Scholar

40 Gupta AK, Stec N. Emerging drugs for the treatment of onychomycosis. Expert Opin Emerg Drugs. 2019;-24(4):213-20. Search in Google Scholar

41 Aslam R, Hussain T, Yousaf AM, Ghori MU, Khan IU, Rizvi SAA, et al. Onychomycosis: current understanding and strategies for enhancing drug delivery into human nail tissue. Curr Drug Res Rev. 2021; 13 (1):25-35. Search in Google Scholar

42 Wang Y, Lipner SR. Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration. J Dermatolog Treat. 2021;32(7):783-7. Search in Google Scholar

43 Ricardo JW, Lipner SR. Safety of current therapies for onychomycosis. Expert Opin Drug Saf. 2020; 19(11):1395-408. Search in Google Scholar

44 Gupta AK, Stec N, Bamimore MA, Foley KA, Shear NH, Piguet V. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol. 2020;34 (3):580-8. Search in Google Scholar

45 Gupta AK, Foley KA, Mays RR, Shear NH, Piguet V. Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis. Br J Dermatol 2020;182(2):287-99. Search in Google Scholar

46 El-Tatawy RA, Aliweh HA, Hegab DS, Talaat RAZ, Shams Eldeen MA. Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. Lasers Med Sci. 2019;34(9):1873-80. Search in Google Scholar